MOLECULAR GENETIC ANALYSIS OF CONGENITAL MEROZIN-NEGATIVE MUSCULAR DYSTROPHY IN RUSSIA
https://doi.org/10.25557/2073-7998.2018.07.38-45
Abstract
Congenital muscular dystrophy (CMD) is a genetically heterogeneous group of diseases, the main clinical manifestation of which is the «floppy» child syndrome, characterized by muscle weakness that occurs immediately after birth or during the first six months of life. The merozin-deficiency muscular dystrophy, caused by mutations in the LAMA2 gene, is the most common form of CMD. This paper presents results of molecular genetic analysis of the LAMA2 gene in 29 unrelated patients with CMD. The spectrum of LAMA2 gene mutations in Russia is described. New allelic variants of the LAMA2 gene have been detected: c.6992+1G>T, c.3829C>T, c.5422C>T, c.6406C>T, c.7888C>T, c.172T>C, c.3dupG, c.4254insCCAT, c.4665dupG, c.7308insGATTGGCTATATCAATTGTATCTATA and c.7701delTinsGTGTCCCTAGGTGTCCCTA. The founder effect for the most frequent in Russia mutation of the LAMA2 gene — c.7536delC is shown, the most probable ancestral haplotype for chromosomes with this mutation is determined.
About the Authors
T. B. Milovidova
Federal State budgetary institution «Research centre for medical genetics»
Russian Federation
Russian Federation
M. V. Bulach
Federal State budgetary institution «Research centre for medical genetics»
Russian Federation
Russian Federation
O. A. Schagina
Federal State budgetary institution «Research centre for medical genetics»
Russian Federation
Russian Federation
A. V. Polyakov
Federal State budgetary institution «Research centre for medical genetics»
Russian Federation
Russian Federation
References
1. Quijano-Roy S, Sparks S, Rutkowski A. LAMA2-Related Muscular Dystrophy. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2014. Available from: http://www.ncbi.nlm.nih.gov/books/NBK97333/
2. Zhang X, Vuolteenaho R, Tryggvason K. Structure of the human laminin alpha2-chain gene (LAMA2), which is affected in congenital muscular dystrophy. J Biol Chem. 1996 Nov 1;271(44):27664-9.
3. Leivo I, Engvall E. Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development. Proc Natl Acad Sci USA. 1988 Mar;85(5):1544-8.
4. Holmberg J, Durbeej M. Laminin-211 in skeletal muscle function. Cell Adh Migr. 2013; 7(1): 111-121.
5. Mendell JR, Bouå DR, Martin PT. The congenital muscular dystrophies: recent advances and molecular insights. Pediatr Dev Pathol. 2006 Nov-Dec;9(6):427-43.
6. Reed UC. Congenital muscular dystrophy. Part I: a review of phenotypical and diagnostic aspects. Arq Neuropsiquiatr. 2009 Mar;67(1):144-68.
7. Muntoni F, Voit T. The congenital muscular dystrophies in 2004: a century of exciting progress. Neuromuscul Disord. 2004 Oct;14(10):635-49.
8. Миловидова ТБ, Щагина ОА, Поляков АВ. Оценка частоты врожденной мышечной дистрофии 1А в РФ с использованием новой медицинской технологии «Система детекции в одной пробирке частых мутаций при врожденных несиндромальных мышечных дистрофиях». Медицинская генетика. 2016;15(3): 30-34.
9. Allamand V, Guicheney P. Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin). Eur J Hum Genet. 2002 Feb;10(2):91-4.
10. Дадали ЕЛ, Руденская ГЕ, Щагина ОА. и др. Мерозин-дефицитная врожденная мышечная дистрофия (ВМД1А). Журнал неврологии и психиатрии им. C. C. Корсакова. 2010; 110 (3): 83-89.
11. Philpot., Bagnall A, King C. et al. Feeding problems in merosin deficient congenital muscular dystrophy. Arch Dis Child. 1999; 80(6): 542-547.
12. Geranmayeh F, Clemen, E, Feng LH. et al. Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations. Neuromuscul Disord. 2010; 20(4): 241-250.
13. Carboni N, Marrosu G, Porcu M. et al. Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin-_2-chain gene: A chance association or a novel phenotype? Muscle Nerve. 2011; 44(5): 826-828.
14. Marques J, Duarte ST, Costa S. et al. Atypical phenotype in two patients with LAMA2 mutations. Neuromuscul Disord. 2014; 24(5): 419-424.
15. Tan E, Topaloglu H, Sewry C. et al. Late onset muscular dystrophy with cerebral white matter changes due to partial merosin deficiency. Neuromuscul Disord. 1997; 7(2): 85-89.
16. Kevelam SH, van Engelen BG, van Berkel CG. et al. LAMA2 mutations in adultonset muscular dystrophy with leukoencephalopathy. Muscle Nerve. 2014; 49(4): 616-617.
17. Рыжкова ОП, Кардымон ОЛ, Прохорчук ЕБ. и др. Руководство по интерпретации данных, полученных методами массового параллельного секвенирования (MPS). // Медицинская генетика. 2017;16(7): 4-17.
18. Di Blasi C, Piga D, Brioschi P et. a l. LAMA2 gene analysis in congenital muscular dystrophy: new mutations, prenatal diagnosis, and founder effect. Arch Neurol. 2005 Oct;62(10):1582-6.
19. Pegoraro E, Marks H, Garcia CA et. al. Laminin alpha2 muscular dystrophy: genotype/phenotype studies of 22 patients. Neurology. 1998 Jul;51(1):101-10.
20. Di Blasi C, Bellafiore E, AM Salih M et. al. Variable disease severity in Saudi Arabian and Sudanese families with c.3924 + 2 T > C mutation of LAMA2. BMC Res Notes. 2011 Dec 13;4:534.
21. Oliveira J, Santos R, Soares-Silva I. et. al. LAMA2 gene analysis in a cohort of 26 congenital muscular dystrophy patients. Clin Genet. 2008; 74(6): 502-512.
22. Oliveira J, Gonñalves A, Oliveira ME et al. Reviewing Large LAMA2 Deletions and Duplications in Congenital Muscular Dystrophy Patients Journal of Neuromuscular Diseases 1 (2014) 169-179.
23. Guicheney P, Vignier N, Zhang X et al. PCR based screening of the laminin 2 chain gene (LAMA2): application to prenatal diagnosis and search for founder effects in congenital muscular dystrophy. J Med Genet 1998;35:211-217.
Review
For citations:
Milovidova T.B., Bulach M.V., Schagina O.A., Polyakov A.V. MOLECULAR GENETIC ANALYSIS OF CONGENITAL MEROZIN-NEGATIVE MUSCULAR DYSTROPHY IN RUSSIA. Medical Genetics. 2018;17(7):38-45. (In Russ.) https://doi.org/10.25557/2073-7998.2018.07.38-45
Views:
979
Email this article 